
The latest release from Bethesda is reminiscent of games like Fallout and Skyrim, but with a new level of wonder and adventure — and a whole lot of polish.
The latest release from Bethesda is reminiscent of games like Fallout and Skyrim, but with a new level of wonder and adventure — and a whole lot of polish.
After nearly three years without a new smartwatch, Withings is kicking off IFA 2023 by announcing not one but two ScanWatch hybrid watches.
The $349.95 ScanWatch 2 is Withings’ latest and greatest hybrid smartwatch, with a new temperature tracking module that uses a combination of
Belkin is embracing the new magnet-enhanced Qi2 wireless charging standard with a pair of new products being announced at Berlin’s IFA 2023 tech show. There’s the BoostCharge Convertible Qi2 Wireless Pad to Stand (yes, that’s the name), which can either work like a
Chinese giant Baidu officially launched its chatbot, Ernie Bot, after the government approved its application, alongside that of several other AI companies.
Ernie Bot is now available for download from app stores or Baidu’s website. Much like its main rival, ChatGPT, users can ask Ernie Bot questions or prompt it to help write market analysis, give marketing slogan ideas, and
The point of cloud gaming is it doesn’t require a powerful PC; a Chromebook should do just fine. Today, Google and Nvidia are ready to prove it by giving away a free, no-strings-attached GeForce Now subscription to every modern
Luc Claessen/Getty Images
Chris Goodney/Bloomberg via Getty Images
The Supreme Court
Damir Sagolj/Reuters
Foreign investors dumped Chinese stocks at a record pace in August as
While there are undoubtedly still Taylor Swift fans out there who are salty with Ticketmaster for causing them to miss out on seeing the Eras Tour live, AMC’s getting ready to offer them a chance to see their idol in all her glory at movie theaters across the country.
The U.S. federal government is taking a significant step closer to becoming tolerant of cannabis. On Wednesday, a leaked letter from the U.S. Health and Human Services revealed that the agency has endorsed the rescheduling of the drug from a Schedule I to Schedule III controlled substance, a more lenient designation.…